Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Publication Fees
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Changes in PD-1- and CTLA-4-bearing blood lymphocytes in ICU COVID-19 patients treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir: a pilot study Changes in PD-1- and CTLA-4-bearing blood lymphocytes in ICU COVID-19 patients treated with Favipiravir/Kaletra or Dexamethasone/Remdesivir: a pilot study
Esmaeil Mortaz, Hamidreza Jamaati, Neda K.Dezfuli, Hakime Sheikhzade, Seyed MohammadReza Hashemian, Neda Dalil Roofchayee, Frazaneh Dastan, Payam Tabarsi, Gert Folkerts, Johan Garssen, Sharon Mumby, Ian M. Adcock
Published: 2023-02-20
MicroRNAs in Human Disease: Commentary
Ian M Adcock, Sharon Mumby
Published: 2021-06-06
1 - 2 of 2 items


2021 Impact Factor: 1.570
2021 CiteScore: 2.1


pISSN: 1735-1502
eISSN: 1735-5249


Chairman:
Mostafa Moin, M.D. 

Editors-in-Chief:
Mohammad Bagher Eslami, PhD.
Shahnaz Rafiei Tehrani, M.D., Ph.D. 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

2.1
2021CiteScore
 
 
23rd percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
Iranian Journal of Allergy, Asthma and Immunology (Bimonthly), pISSN: 1735-1502, eISSN: 1735-5249
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.